Therapy of herpes simplex virus infections: a prospective view.
D000937:Antigen-Antibody Reactions; D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D003561:Cytarabine / Q000627:therapeutic use; D004279:DNA, Viral; D003907:Dexamethasone / Q000627:therapeutic use; D006561:Herpes Simplex / Q000188:drug therapy / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012008:Recurrence; D018139:Simplexvirus / Q000254:growth & development / Q000276:immunology / Q000472:pathogenicity; D014762:Viral Interference; D014779:Virus Replication; D005719:gamma-Globulins / Q000627:therapeutic use
D000998:Antiviral Agents; D004279:DNA, Viral; D005719:gamma-Globulins; D003561:Cytarabine; D003907:Dexamethasone; D007372:Interferons; D011241:Prednisone